Sato Kanji, Omi Yoko, Kodama Hitomi, Obara Takao, Yamazaki Kazuko, Yamada Emiko, Seki Toshiro, Takano Kazue, Shiga Tsuyoshi, Kasanuki Hiroshi
Department of Medicine, Institute of Clinical Endocrinology, Tokyo Women's Medical University, Tokyo.
Intern Med. 2008;47(8):757-62. doi: 10.2169/internalmedicine.47.0843. Epub 2008 Apr 16.
We report the treatment of four thyrotoxic patients. Two were cases of type I amiodarone-induced thyrotoxicosis (AIT) treated with methimazole. The third Graves' disease patient, who became hypothyroid 25 years after subtotal thyroidectomy, developed type II AIT. Furthermore, one case with heart failure and ventricular tachycardia, who developed an adverse reaction to antithyroid agents and was prescribed amiodarone, underwent total thyroidectomy. The clinical course was uneventful, and the patient is doing well. Since amiodarone contains a large amount of iodine, it is frequently difficult to make a differential diagnosis. Surgical treatment of Graves' disease patients is recommended when immediate control of hyperthyroidism and heart failure is required.
我们报告了4例甲状腺毒症患者的治疗情况。其中2例为I型胺碘酮所致甲状腺毒症(AIT),接受了甲巯咪唑治疗。第3例格雷夫斯病患者在甲状腺次全切除术后25年出现甲状腺功能减退,继而发生II型AIT。此外,1例伴有心力衰竭和室性心动过速的患者对抗甲状腺药物出现不良反应,服用胺碘酮后接受了甲状腺全切除术。临床过程平稳,患者恢复良好。由于胺碘酮含有大量碘,常常难以进行鉴别诊断。当需要立即控制甲亢和心力衰竭时,建议对格雷夫斯病患者进行手术治疗。